Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Cardiovascular Drugs and Therapy|November 29, 2011
Nonclinical pharmacokinetics of a new nonpeptide V2 receptor antagonist, tolvaptanMasayuki Furukawa, Ken Umehara, Eiji Kashiyama
Best Practice & Research. Clinical Gastroenterology|October 29, 2005
Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatmentK Martin Hoffmann, Masayuki Furukawa, Robert T Jensen
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 13, 2014
Enantioselective analysis of tolvaptan in rat and dog sera by high-performance liquid chromatography and application to pharmacokinetic studyMasayuki Furukawa, Yuko Yamasaki, Yukihiro Hirao, et al.
Acta Oto-Laryngologica|January 25, 2003
Presence of platelet-activating factor in nasal polyps and eosinophilsMasayuki Furukawa, Manabu Ogura, Toshiyuki Tsutsumi, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 18, 2010
Expression of IL-17 and its role in bone destruction in human middle ear cholesteatomaTakuo Haruyama, Masayuki Furukawa, Takeshi Kusunoki, et al.
Auris, Nasus, Larynx|November 13, 2007
Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle earManabu Ogura, Masayuki Furukawa, Naoki Tada, et al.
Auris, Nasus, Larynx|May 16, 2008
Laryngeal stenosis in epidermolysis bullosa dystrophicaTakuo Haruyama, Masayuki Furukawa, Fumihiko Matsumoto, et al.
Acta Oto-Laryngologica|July 9, 2008
Effect of resection of the posterior nasal nerve on functional and morphological changes in the inferior turbinate mucosaKatsuhisa Ikeda, Hidenori Yokoi, Tatsuya Saito, et al.
Pageof 9